An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
Clinical trial NCT05295433 · RECRUITING
Trial details
- NCT number
- NCT05295433
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2034-04-02
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.